Anti-Mullerian Hormone (AMH) has emerged as a crucial biomarker in understanding and evaluating female fertility. Produced by the developing ovarian follicles, AMH has become a valuable tool for assessing ovarian reserve and predicting a woman’s reproductive potential.
Ovarian reserve and AMH
Ovarian reserve refers to the quantity and quality of a woman’s eggs, reflecting her reproductive capacity. AMH levels are directly linked to ovarian reserve, making it an informative marker for assessing fertility. Unlike other fertility markers that fluctuate throughout the menstrual cycle, AMH levels remain relatively stable, making it a reliable indicator.
Predicting fertility
AMH is particularly useful in predicting the ovarian response to fertility treatments such as in vitro fertilization (IVF). Women with lower AMH levels may have a diminished ovarian reserve, indicating a potential challenge in responding to ovarian stimulation during fertility treatments. Conversely, higher AMH levels may suggest a more robust ovarian reserve and an increased likelihood of a successful response to fertility interventions.
